Circle (CRCL) stock rises 2.83% as USDC launches natively on Injective with CCTP support, enabling secure crosschain transfers and enhanced liquidity.

Injective price surges more than 13% on Thursday, approaching a key resistance level. Injective announced that its IIP-619 proposal passed, enabling a mainnet upgrade on Thursday. The upgrade aims to ...

Andriy Blokhin has 5+ years of professional experience in public accounting, personal investing, and as a senior auditor with Ernst & Young. Erika Rasure is globally-recognized as a leading consumer ...

Jay N. Yepuri, MD, MS, FACG, is a board-certified gastroenterologist and member of the Digestive Health Associates of Texas Board of Directors and Executive Committee. A liver function test checks how ...

The immune system is a complex network that finds pathogens, removes damaged cells, and launches immune responses to protect the body from infection. White blood cells drive this defense: phagocytes ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Getty Images The IMF promotes global ...

Injective (INJ) surged over 12% today, signaling renewed investor attention. What factors are driving this rally?